- Report
- February 2024
- 175 Pages
Global
From €4766EUR$5,000USD£4,088GBP
- Report
- May 2024
- 194 Pages
Global
From €5194EUR$5,450USD£4,456GBP
- Report
- October 2023
- 178 Pages
Global
From €4670EUR$4,900USD£4,006GBP
- Report
- September 2020
- 175 Pages
Global
From €3036EUR$3,185USD£2,604GBP
€4337EUR$4,550USD£3,720GBP
- Report
- June 2020
- 111 Pages
Global
From €4527EUR$4,750USD£3,884GBP
- Report
- January 2022
- 200 Pages
Global
From €7148EUR$7,500USD£6,132GBP
- Report
- January 2022
- 60 Pages
Global
From €3765EUR$3,950USD£3,230GBP
- Report
- June 2023
- 108 Pages
Global
From €3500EUR$3,934USD£3,107GBP
- Report
- August 2023
- 479 Pages
Global
From €3403EUR$3,570USD£2,919GBP
- Report
- February 2024
- 180 Pages
Global
From €5241EUR$5,499USD£4,496GBP
Chronic Idiopathic Constipation (CIC) is a type of Gastroenterology disorder characterized by infrequent bowel movements and difficulty passing stools. It is a common condition that affects millions of people worldwide. Symptoms of CIC include abdominal pain, bloating, and feeling of incomplete evacuation. Treatment options for CIC include lifestyle modifications, dietary changes, and medications. Laxatives are the most commonly prescribed medications for CIC, but other treatments such as probiotics, fiber supplements, and biofeedback may also be used.
The CIC market is a growing segment of the Gastroenterology market, with a focus on developing new treatments and improving existing treatments. Companies in the CIC market include Allergan, Ironwood Pharmaceuticals, Synergy Pharmaceuticals, and Salix Pharmaceuticals. Show Less Read more
